Difference between revisions of "Vorinostat"

From OncoWiki
Jump to: navigation, search
(Created page with "==Vorinostat (Zolinza) maintenance== Preceded by [[#Cytarabine_.28Cytosar.29.2C_Idarubicin_.28Idamycin.29.2C_Vorinostat_.28Zolinza.29_consolidation|Cytarabine (Cytosar), Idaru...")
m (Vorinostat (Zolinza) maintenance)
Line 1: Line 1:
==Vorinostat (Zolinza) maintenance==
==Vorinostat (Zolinza) maintenance==
Preceded by [[#Cytarabine_.28Cytosar.29.2C_Idarubicin_.28Idamycin.29.2C_Vorinostat_.28Zolinza.29_consolidation|Cytarabine (Cytosar), Idarubicin (Idamycin), Vorinostat (Zolinza) consolidation]] therapy.  
Preceded by [[Cytarabine_Idarubicin_Vorinostat_consolidation]] consolidation therapy.  
*[[Vorinostat (Zolinza)]] 200 mg PO TID on days 1-14
*[[Vorinostat (Zolinza)]] 200 mg PO TID on days 1-14

Latest revision as of 03:55, 9 October 2012

Vorinostat (Zolinza) maintenance

Preceded by Cytarabine_Idarubicin_Vorinostat_consolidation consolidation therapy.


28-day cycles x up to 12 cycles


  1. Garcia-Manero G, Tambaro FP, Bekele NB, Yang H, Ravandi F, Jabbour E, Borthakur G, Kadia TM, Konopleva MY, Faderl S, Cortes JE, Brandt M, Hu Y, McCue D, Newsome WM, Pierce SR, de Lima M, Kantarjian HM. Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome. J Clin Oncol. 2012 Jun 20;30(18):2204-10. Epub 2012 May 14. link to original article contains verified protocol PubMed